Journal article
The effect of increasing doses of β-agonists on airflow in patients with chronic airflow limitation
Abstract
OBJECTIVE: To determine the increase in FEV1 associated with increasing doses of inhaled terbutaline and salbutamol, the reproducibility of the increase in FEV1, and the reproducibility of the associated optimal bronchodilator dose, in patients with chronic airflow limitation (CAL).
DESIGN: Double-blind, randomized, controlled trial examining spirometric response to cumulative doses of bronchodilators.
Authors
Jaeschke R; Guyatt GH; Cook D; Morris J; Willan A; McIlroy W; Harper S; Ramsdale H; Haddon R; Fitzgerald MJ
Journal
Respiratory Medicine, Vol. 87, No. 6, pp. 433–438
Publisher
Elsevier
Publication Date
August 1993
DOI
10.1016/0954-6111(93)90069-c
ISSN
0954-6111